U.S. Logistics Stock News

NYSE:CC
NYSE:CCChemicals

Is Chemours (CC) A Bargain As Its PFAS Settlement Clarifies Long Term Risks?

Chemours (CC) stock is in focus after the company agreed to a regulatory settlement over PFAS discharges, committing to a US$22.5 million civil penalty and US$90 million of long term mitigation projects. See our latest analysis for Chemours. The PFAS settlement landed after a strong run for Chemours, with the share price up 64.41% year to date at US$20.14. However, recent 30 day and 7 day share price returns of 9.77% and 4.87% respectively indicate that momentum has cooled and reflect longer...
NYSE:MOH
NYSE:MOHHealthcare

Molina Healthcare (MOH) Gets A Payment Boost, Is The Stock Still A Bargain?

Molina Healthcare (MOH) is in focus after new 2025 risk adjustment figures from the Centers for Medicare & Medicaid Services pointed to higher than expected payments for the company, alongside fresh index reclassifications and value-focused research coverage. See our latest analysis for Molina Healthcare. The recent risk adjustment update and index reshuffling come at a time when Molina Healthcare’s share price momentum has been strong, with a 30 day share price return of 26.9% and a 90 day...
NasdaqGS:ABSI
NasdaqGS:ABSIBiotechs

Absci (ABSI) Is Up 10.3% After Positive ABS-201 Phase 1 Data And $100M Equity Raise

In late June 2026, Absci Corporation reported positive interim Phase 1 data from its HEADLINE trial of ABS-201 for androgenetic alopecia, showing favorable safety, an estimated half-life of at least 65 days, and progression into multiple ascending dose cohorts, while also completing a US$100.00 million follow-on equity offering of 13,495,277 common shares at US$7.41 each. The combination of encouraging early data for a long-acting, antibody-based hair loss therapy and fresh equity capital...
NYSE:WRB
NYSE:WRBInsurance

W. R. Berkley (WRB) Names John Enright After Lucille Sgaglione Resigns

W. R. Berkley (NYSE:WRB) has announced the resignation of Executive Vice President Lucille Sgaglione. The company has appointed John Enright as president of Berkley Specialty London. These leadership moves affect a key business segment that draws attention from investors tracking executive decision making. W. R. Berkley enters these leadership changes with its stock at $70.66 and a long term return of 134.5% over the past 5 years. Over the past 3 years, the stock is up 92.2%, while the 1...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Zions Bancorporation National Association (ZION) Could Be 52% Undervalued Following Russell Index Inclusion

Zions Bancorporation National Association (ZION) has been added to the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, a shift that can influence institutional attention and index-tracking fund flows. See our latest analysis for Zions Bancorporation National Association. Zions Bancorporation National Association has seen momentum build recently, with a 1 month share price return of 15.75% and a 1 year total shareholder return of 33.25%, alongside a very large 3 year...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Dividend Stocks for Steady Income as Rates Stay Higher for Longer

With the Federal Reserve expected to keep the effective funds rate around 3.63% to 3.64% through 2026 and core PCE inflation sitting at 3.3%, income focused investors are paying closer attention to how reliable dividend stocks handle a long stretch of steady rates. Rather than chasing whatever is moving, it can help to focus on large, established companies that already have a history of consistent payouts. This article looks at three dividend stocks from our screener that appear closely tied...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Does Acadia Healthcare (ACHC) Joining the Russell 2000 Reframe Its Behavioral Health Investment Narrative?

On June 27, 2026, Acadia Healthcare Company was removed from the Russell 1000, Midcap and related value/dynamic benchmarks, while being added to the Russell 2000 Index and its value and dynamic counterparts as part of the Russell index reconstitution. This shift effectively recategorizes Acadia Healthcare into the smaller‑capitalization value universe, which can alter its investor base, trading liquidity and how portfolio managers frame its role within behavioral health exposure. Next, we’ll...
NYSE:MTZ
NYSE:MTZConstruction

The Bull Case For MasTec (MTZ) Could Change Following Board Shake-Up And Russell Index Removal

MasTec, Inc. recently added veteran utility executive Manny Miranda to its Board as a Class II Director, while the company was also removed from several Russell value and growth benchmarks in late June 2026. His four decades of hands-on experience in electric and natural gas utility operations could deepen MasTec’s insight into grid modernization and energy infrastructure challenges. With Miranda’s utility expertise now on the board, we’ll examine how these developments may influence...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Advanced Energy Industries (AEIS) Gains AI And Chip Spending Buzz As Valuation Questions Linger

Advanced Energy Industries (AEIS) has been catching investor attention after a sharp move in the stock, supported by strong sector momentum, upbeat semiconductor spending forecasts, recent Russell index inclusions, and activity around new AI data center products. See our latest analysis for Advanced Energy Industries. The share price of Advanced Energy Industries has eased 4.4% over the last day and is roughly flat over the past week. However, a 20.9% 1 month share price return and 60.5% year...
NYSE:GENI
NYSE:GENIHospitality

Is Genius Sports (GENI) Undervalued After Its Russell Value Index Inclusions?

Index inclusions put Genius Sports in focus Genius Sports (GENI) is drawing fresh investor attention after being added to several Russell value indices, including the Russell 2000 Value and 2500 Value benchmarks, a shift that can influence institutional demand. See our latest analysis for Genius Sports. The index inclusions arrive after a sharp 39.47% 90 day share price return and a 12.37% 7 day share price return, set against a year to date share price decline of 41% and a 1 year total...
NYSE:SXT
NYSE:SXTChemicals

Should Sensient Technologies’ New US$400 Million Delayed-Draw Loan Shape How Investors View SXT’s Balance Sheet?

Sensient Technologies recently entered into a new unsecured delayed-draw term loan credit facility of up to US$400,000,000, maturing in five years, to refinance existing debt and support working capital and other general corporate purposes. The agreement’s flexible draw structure, leverage and interest coverage covenants, and option to prepay without penalty could meaningfully influence Sensient’s balance sheet management and funding costs. We’ll now examine how this US$400,000,000...
NYSE:ACVA
NYSE:ACVACommercial Services

Is ACV Auctions (ACVA) Undervalued As Russell Index Inclusion Draws Fresh Investor Attention?

ACV Auctions (ACVA) was added to several Russell value and small cap benchmarks, including the Russell 2000 Value and Russell 3000 Value indices. This shift can influence index fund activity and overall investor attention. See our latest analysis for ACV Auctions. ACV Auctions' inclusion in several Russell value indices comes after a sharp 67.2% 3 month share price return to US$7.29, even though the year to date share price return is down 12.06% and the 1 year total shareholder return has...
NasdaqGS:QLYS
NasdaqGS:QLYSSoftware

Why Qualys (QLYS) Is Up 24.4% After JPMorgan’s Cybersecurity Reassessment And What It Suggests

In late June 2026, JPMorgan upgraded its rating on Qualys after reassessing the company’s position in the expanding vulnerability management segment and broader cybersecurity services market. This reassessment highlights how Qualys’ core role in helping enterprises proactively identify and prioritize security risks is becoming more central as organizations modernize their defenses. We’ll now explore how this renewed confidence in Qualys’ vulnerability management strength may influence its...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap?

PROCEPT BioRobotics (PRCT) drew fresh attention after Evercore ISI initiated coverage, alongside two new Aquablation milestones: full enrollment in the WATER IV RP trial and FDA IDE approval for a second prostate cancer study. See our latest analysis for PROCEPT BioRobotics. At a share price of US$23.47, PROCEPT BioRobotics has seen a 7 day share price return of 12.57% following the Evercore ISI coverage and clinical milestones, but this sits against a 1 year total shareholder return that...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

Is Interparfums (IPAR) Fully Valued Following Strong Margins And Free Cash Flow?

Interparfums (IPAR) has drawn fresh attention after a session where the stock rose 3.4% to $115.67, helped by investor focus on its high gross margins, solid free cash flow, and recent outperformance. See our latest analysis for Interparfums. The recent 3.4% one day share price return and 10.9% 7 day share price return sit on top of a 25.2% 30 day share price return and 35.4% year to date share price return. In contrast, the 1 year total shareholder return is down 12.9% and the 3 year total...
NasdaqGS:HBNC
NasdaqGS:HBNCBanks

How Investors May Respond To Horizon Bancorp (HBNC) Jury Verdict And Indirect Auto Lending Exit

Horizon Bancorp recently recorded an approximate US$3.0 million pre-tax reserve after a June 24, 2026 jury awarded nearly US$3.0 million in damages against its Horizon Bank subsidiary over a 2018 indirect auto repossession and credit reporting dispute, and the company has said it plans to appeal the punitive component. An interesting wrinkle for investors is that Horizon had already exited most of its indirect auto lending exposure by 2024, and now characterizes the verdict as isolated with...
NYSE:DOLE
NYSE:DOLEFood

Is Dole (DOLE) Undervalued After Its Ecuador Port Sale?

Dole (NYSE:DOLE) has closed the sale of its port and port operations in Guayaquil, Ecuador, to TIL Switzerland Sàrl, receiving about US$75 million in cash after costs and transaction adjustments. See our latest analysis for Dole. Dole’s latest port sale comes after a period where the share price has eased, with the 90 day share price return down 5.7% and the year to date share price return down 6.15%. The 3 year total shareholder return is 12.26%, suggesting longer term holders have seen...
NYSE:BOW
NYSE:BOWInsurance

Bowhead Specialty (BOW) Is Up 7.3% After Shift Into Russell Value Indices What’s Changed

On 27 June 2026, Bowhead Specialty Holdings Inc. (NYSE: BOW) was reclassified across Russell indices, moving from growth benchmarks into several value-focused indices including the Russell 3000 Value and Russell 2000 Value. This shift in index membership highlights how the market now groups Bowhead more with value-oriented insurers, potentially affecting which institutional investors track or hold the stock. Next, we'll examine how this reclassification toward value indices interacts with...
NYSE:LYV
NYSE:LYVEntertainment

Live Nation Entertainment (LYV) Could Be 15% Undervalued Following Lowe's Partnership

Live Nation Entertainment (LYV) is back in focus after a multi-year partnership with Lowe's tied the concert giant to the retailer's loyalty program, while investors also weigh strong demand signals and unresolved antitrust remedies. See our latest analysis for Live Nation Entertainment. At a share price of $183.98, Live Nation Entertainment has seen momentum build over recent months, with a 30-day share price return of 7.94% and a 90-day gain of 18.13%. The 5-year total shareholder return of...
NYSE:CCI
NYSE:CCISpecialized REITs

Crown Castle (CCI) Moves Ahead With Tower Only Shift As Leadership Changes Take Shape

Crown Castle (NYSE:CCI) is advancing its plan to become a pure-play tower REIT. The company is pursuing the sale of its fiber and small-cell business as part of this shift. Recent executive leadership changes are aligned with the new tower-focused strategy. Crown Castle operates wireless towers and related infrastructure that support mobile connectivity for carriers and other customers. By concentrating on its tower portfolio and exiting the fiber and small-cell segment, the company is...